Fabian M.
- Country
- Germany
- Department
- Medizinische Klinik 5 – Hämatologie und Internistische Onkologie
Research Overview
- Evaluation of BI 3000202 Pharmacokinetics and Tolerability in Healthy Male Volunteers Under Fed and Fasted Conditions
- Pharmacokinetic Evaluation of Zongertinib on Dabigatran, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
- Efficacy and Safety of Golcadomide with R-CHOP Versus Placebo with R-CHOP in High-risk Large B-cell Lymphoma: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 60 of 224 partner sites.
Specializations
Lymphoma Research
Specializes in the treatment of large B-cell lymphoma, with particular emphasis on developing innovative therapeutic approaches for previously untreated patients.
- Aggressive B-cell lymphoma treatment
- High-risk LBCL management
- First-line therapy optimization
Investigates novel combination therapies incorporating targeted antibodies and immunotherapeutic agents.
Therapeutic Development
Focuses on evaluating novel therapeutic combinations including antibody-drug conjugates and bispecific antibodies for lymphoma treatment.
- Chemotherapy-light approaches
- Rituximab-based combinations
- CAR-T cell therapy assessment
Studies comparative efficacy of emerging treatments against standard-of-care therapies.
Clinical Pharmacology
Conducts research in pharmacokinetic interactions and drug metabolism, with emphasis on novel therapeutic agents.
- Drug interaction studies
- Bioavailability assessment
- Safety evaluation in healthy volunteers
Examines the influence of various factors on drug absorption and metabolism.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.